Blood Biomarkers May Help ID Primary CNS Lymphoma, High-Grade Glioma - HealthDay News


4/18/2022 12:00:00 AM3 yearsago
by Physician’s Briefing Staff

Systemic inflammatory biomarkers may be useful in the differential diagnosis of primary central nervous system lymphoma, high-grade glioma

MONDAY, April 18, 2022 (HealthDay News) -- Systemic inflammatory biomarkers may aid in differentiating primary central nervous system lymphoma (PCNSL) from high-grade glioma (HGG), according to a stu… [+1051 chars]

full article...